Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02499575 · ClinicalTrials.gov registry record · NA
Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures
A NA study, sponsored by OhioHealth.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02499575: Clinical Trial NA study, sponsored by OhioHealth.
NCT02499575 is a NA study that was terminated before completion, run by OhioHealth. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02499575, a NA study, was terminated before completion, sponsored by OhioHealth.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Exparel is an FDA-approved local anesthetic (bupivacaine), in a long-release formulation. In this study the investigators plan to determine the ability of Exparel to control post-operative pain in common first metatarsophalangeal (MTP) joint procedures (bunion surgery, 1st MTP fusion, and cheilectomy).
Primary Outcome
Compare time to first opioid use over 72 hours between groups
Interventions
- DRUG Exparel
- DRUG 0.5% ropivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-07 |
| Phase | NA |
Why NCT02499575 stopped before completion
NCT02499575 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Exparel is the first listed.
NCT02499575 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02499575 about?
NCT02499575 is a clinical study titled "Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures". Exparel is an FDA-approved local anesthetic (bupivacaine), in a long-release formulation. In this study the investigators plan to determine the ability of Exparel to control post-operative pain in common first metatarsophalangeal (MTP) joint procedures (bunion surgery, 1st MTP fusion, and cheilectom...
What is the current status of trial NCT02499575?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2015-07. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02499575?
The interventions under investigation include: Exparel (DRUG), 0.5% ropivacaine (DRUG).
Who is sponsoring clinical trial NCT02499575?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02499575's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia